Company News

bioMérieux, a world leader in the field of in vitro diagnostics since 1963, announces the launch of GENE-UP^® QUANT Salmonella, the first, and only, AOAC approved true non-enrichment quantification diagnostic for Salmonella.

bioMérieux, a world leader in the field of in vitro diagnostics, announces the approval of the cutting-edge diagnostic assay for the detection of pathogenic E. coli., a bacterium that is commonly found in the human gastrointestinal tract.

bioMérieux, a world leader in the field of in vitro diagnostics announced today the launch of GENE-UP^® PRO ACB, a new assay for juice quality and safety programs.

Bringing an added level of confidence to the robust science that its assay offers, the bioMérieux, Inc. GENE-UP^® NUTRAPLEX PRO™ multiplex pathogen detection assay has achieved the AOAC® Research Institute Performance Tested Methods℠ approval (PTM 082103).

bioMérieux, a world leader in the field of in vitro diagnostics, is pleased to announce that it has received AOAC INTERNATIONAL Performance Tested Method℠ approval for its GENE-UP® PRO STEC / Salmonella assay, for the simultaneous enrichment and detection of STEC (Shiga Toxigenic Escherichia coli) and Salmonella spp. in cannabis samples.